Cargando…
Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441957/ http://dx.doi.org/10.1038/sj.bjc.6604414 |
_version_ | 1782156651415994368 |
---|---|
author | Maeda, J Hirano, T Ogiwara, A Akimoto, S Kawakami, T Fukui, Y Oka, T Gong, Y Guo, R Inada, H Nawa, K Kojika, M Suga, Y Ohira, T Mukai, K Kato, H |
author_facet | Maeda, J Hirano, T Ogiwara, A Akimoto, S Kawakami, T Fukui, Y Oka, T Gong, Y Guo, R Inada, H Nawa, K Kojika, M Suga, Y Ohira, T Mukai, K Kato, H |
author_sort | Maeda, J |
collection | PubMed |
description | |
format | Text |
id | pubmed-2441957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-24419572009-09-10 Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy Maeda, J Hirano, T Ogiwara, A Akimoto, S Kawakami, T Fukui, Y Oka, T Gong, Y Guo, R Inada, H Nawa, K Kojika, M Suga, Y Ohira, T Mukai, K Kato, H Br J Cancer Corrigendum Nature Publishing Group 2008-06-17 2008-06-10 /pmc/articles/PMC2441957/ http://dx.doi.org/10.1038/sj.bjc.6604414 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Corrigendum Maeda, J Hirano, T Ogiwara, A Akimoto, S Kawakami, T Fukui, Y Oka, T Gong, Y Guo, R Inada, H Nawa, K Kojika, M Suga, Y Ohira, T Mukai, K Kato, H Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy |
title | Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy |
title_full | Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy |
title_fullStr | Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy |
title_full_unstemmed | Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy |
title_short | Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy |
title_sort | proteomic analysis of stage i primary lung adenocarcinoma aimed at individualization of postoperative therapy |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441957/ http://dx.doi.org/10.1038/sj.bjc.6604414 |
work_keys_str_mv | AT maedaj proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT hiranot proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT ogiwaraa proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT akimotos proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT kawakamit proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT fukuiy proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT okat proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT gongy proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT guor proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT inadah proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT nawak proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT kojikam proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT sugay proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT ohirat proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT mukaik proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy AT katoh proteomicanalysisofstageiprimarylungadenocarcinomaaimedatindividualizationofpostoperativetherapy |